Dina Radenkovic has set out to reshape women’s health.

Gameto, her start-up based in Austin, has spent the last four years working on stem cell engineering technology that it expects to aim at things ranging from fertility treatments to menopause. On the fertility front, Gameto already has a product called Fertilo that reduces the time women must go through painful, hormonal injections from two weeks down to a couple of days. It’s been approved for use in several countries and is being studied now in a clinical trial in the U.S.

Fertilo works by replicating ovarian cells in a lab and using those cells to mature eggs outside of the body. It’s another example of the iSPC, or induced pluripotent stem cells, technology that has the bio-tech world so excited.

Radenkovic hopes that similar technology can be applied to menopause in the future and lessen the dramatic hormonal shifts women experience.

Born in Serbia, Radenkovic is a doctor and has raised $73 million in venture funding for Gameto to date.